ITMI911095A0 - Composizioni farmaceutiche contenenti l'estere 4-(2 metilamminoetil)- 1,2- fenilenicodell`acido 2-metilpropanoico per il trattamento della neurootticopatia glaucomatosa - Google Patents

Composizioni farmaceutiche contenenti l'estere 4-(2 metilamminoetil)- 1,2- fenilenicodell`acido 2-metilpropanoico per il trattamento della neurootticopatia glaucomatosa

Info

Publication number
ITMI911095A0
ITMI911095A0 IT91MI1095A ITMI911095A ITMI911095A0 IT MI911095 A0 ITMI911095 A0 IT MI911095A0 IT 91MI1095 A IT91MI1095 A IT 91MI1095A IT MI911095 A ITMI911095 A IT MI911095A IT MI911095 A0 ITMI911095 A0 IT MI911095A0
Authority
IT
Italy
Prior art keywords
neuropticopathy
phenylenic
glaucomatous
methylaminoethyl
ester
Prior art date
Application number
IT91MI1095A
Other languages
English (en)
Inventor
Michele Virno
Annibale Gazzaniga
Original Assignee
Zambon Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambon Spa filed Critical Zambon Spa
Priority to ITMI911095A priority Critical patent/IT1247508B/it
Publication of ITMI911095A0 publication Critical patent/ITMI911095A0/it
Priority to US07/866,415 priority patent/US5227404A/en
Priority to EP92201038A priority patent/EP0509598B1/en
Priority to DE69206184T priority patent/DE69206184T2/de
Priority to AT92201038T priority patent/ATE130513T1/de
Priority to JP4095434A priority patent/JPH05112450A/ja
Publication of ITMI911095A1 publication Critical patent/ITMI911095A1/it
Application granted granted Critical
Publication of IT1247508B publication Critical patent/IT1247508B/it

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
ITMI911095A 1991-04-19 1991-04-19 Composizioni farmaceutiche contenenti l'estere 4-(2 metilamminoetil)- 1,2- fenilenicodell`acido 2-metilpropanoico per il trattamento della neurootticopatia glaucomatosa IT1247508B (it)

Priority Applications (6)

Application Number Priority Date Filing Date Title
ITMI911095A IT1247508B (it) 1991-04-19 1991-04-19 Composizioni farmaceutiche contenenti l'estere 4-(2 metilamminoetil)- 1,2- fenilenicodell`acido 2-metilpropanoico per il trattamento della neurootticopatia glaucomatosa
US07/866,415 US5227404A (en) 1991-04-19 1992-04-10 Pharmaceutical composition for the treatment of glaucomatous optic neuropathy
EP92201038A EP0509598B1 (en) 1991-04-19 1992-04-11 Use of ibopamine for the manufacture of a pharmaceutical composition for the treatment of glaucomatous optic neuropathy
DE69206184T DE69206184T2 (de) 1991-04-19 1992-04-11 Verwendung von Ibopamin zur Herstellung eines Arzneimittels zur Behandlung der optischen Neuropathie bei Glaukom.
AT92201038T ATE130513T1 (de) 1991-04-19 1992-04-11 Verwendung von ibopamin zur herstellung eines arzneimittels zur behandlung der optischen neuropathie bei glaukom.
JP4095434A JPH05112450A (ja) 1991-04-19 1992-04-15 緑内障性の視神経病の治療のための薬剤組成およびその治療法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI911095A IT1247508B (it) 1991-04-19 1991-04-19 Composizioni farmaceutiche contenenti l'estere 4-(2 metilamminoetil)- 1,2- fenilenicodell`acido 2-metilpropanoico per il trattamento della neurootticopatia glaucomatosa

Publications (3)

Publication Number Publication Date
ITMI911095A0 true ITMI911095A0 (it) 1991-04-19
ITMI911095A1 ITMI911095A1 (it) 1992-10-19
IT1247508B IT1247508B (it) 1994-12-17

Family

ID=11359710

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI911095A IT1247508B (it) 1991-04-19 1991-04-19 Composizioni farmaceutiche contenenti l'estere 4-(2 metilamminoetil)- 1,2- fenilenicodell`acido 2-metilpropanoico per il trattamento della neurootticopatia glaucomatosa

Country Status (6)

Country Link
US (1) US5227404A (it)
EP (1) EP0509598B1 (it)
JP (1) JPH05112450A (it)
AT (1) ATE130513T1 (it)
DE (1) DE69206184T2 (it)
IT (1) IT1247508B (it)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003032969A2 (en) * 2001-10-15 2003-04-24 National Research Council Of Canada Anti-glycation agents for preventing age-, diabetes-, and smoking-related complications
ITMI20040146A1 (it) * 2004-01-30 2004-04-30 Acraf Ibopamina maleato metodo per prepararlo e composizioni farmaceutiche che lo comprendono

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1178800B (it) * 1984-12-27 1987-09-16 Simes Composizioni farmaceutiche e loro uso come midriatici
DE3514508A1 (de) * 1985-04-22 1986-10-30 Kailash Kumar Prof. Dr. 2359 Lentföhrden Gauri Verwendung von dopamin und dessen ester bei der behandlung von glaukom
IT1229846B (it) * 1989-04-20 1991-09-13 Simes Esteri di catecolammine.

Also Published As

Publication number Publication date
ATE130513T1 (de) 1995-12-15
DE69206184T2 (de) 1996-09-05
EP0509598B1 (en) 1995-11-22
DE69206184D1 (de) 1996-01-04
US5227404A (en) 1993-07-13
JPH05112450A (ja) 1993-05-07
EP0509598A1 (en) 1992-10-21
ITMI911095A1 (it) 1992-10-19
IT1247508B (it) 1994-12-17

Similar Documents

Publication Publication Date Title
EG17753A (en) Novel pharmacological compounds
GR3019388T3 (en) The use of buspirone for preparing a pharmaceutical composition for the treatment of alcohol abuse
FI920023A0 (fi) Heteroarylpiperazinfoereningar som antipsykotiska aemnen.
SE8404065D0 (sv) Novel biologically active compounds
PT85128A (en) Process for the preparation of pharmaceutical compounds containing as active ingredient 4-(1-methyl-4-piperydilidene)-4h-benzo-(4,5)-cyclohepta(1,2-b)thiophene-10(9h)-one
FI880467A (fi) Menetelmä terapeuttisesti käyttökelpoisten substituoitujen 3,4-dihydro-2H-bentsopyraanien valmistamiseksi
PT86635A (pt) Process for the preparation of novel 4-aryl-n-]2-(dialkylamino and heterocyclicamino)-alkyl"-1-piperazinecarboxamides and of pharmaceutical compositions containing the same
NO175976C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 4-(1,6-dihydro-6-okso-pyridazinyl-3-oksy)-3-kromanolderivater
ITRM910430A1 (it) Composizioni farmaceutiche di somatostatina con assorbimento migliorato, loro preparazione e loro impiego
FI900145A0 (fi) Menetelmä farmaseuttisesti käyttökelpoisten 1,1-diokso-kefem-4-karbotiolihappojohdannaisten valmistamiseksi
DE69231883D1 (de) 4-(1,1-Dialkoxycarbonyl-Alkyl)Azetidin-2-on-Derivate zur Herstellung von 4-(1-Carboxy-Alkyl)Azetidin-2-on-Derivaten
ITMI911095A0 (it) Composizioni farmaceutiche contenenti l'estere 4-(2 metilamminoetil)- 1,2- fenilenicodell`acido 2-metilpropanoico per il trattamento della neurootticopatia glaucomatosa
FI93216C (fi) Analogiamenetelmä terapeuttisesti käyttökelpoisten 1,3-dioksaanialkeenihappojohdannaisten valmistamiseksi
NO164243C (no) Analogifremgangsmaate for fremstilling av nye terapeutisk aktive 16,17-acetalsubstituerte pregnan-21-oinsyrederivater
IL85651A (en) Preparation of optically active oxo-isoindolinyl derivatives,some such novel dextrorotary isomers and pharmaceutical compositions containing the novel compounds
ZA88639B (en) Substituted 3-phenyl-7h-thiazolo(3,2-b)(1,2,4)triazin-7-ones,a process for the preparation thereof,medicaments containing same and the use thereof,and also some intermediates formed in the preparation of the compounds mentioned
NO863005D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,4,5,6,7,8-heksahydro-2-alkyl-4-aryl-5-okso-1,7-naftyridin-3-karboksylsyreesterderivater.
NO922638L (no) Anvendelse av 9,12,15-oktadecatrien-6-ynsyre
ITMI911310A1 (it) Procedimento per la preparazione dell'acido 2, 5-diidrossifenilacetico
RO91634A2 (ro) Procedeu de obtinere a esterilor triciclo-5,2,1,0-dec-3-en-8(9)-olului
IL89472A0 (en) Pharmaceutical compositions containing sufotidine for the treatment of inflammatory conditions
IT9021967A0 (it) Composizioni farmaceutiche contenenti acido 2-(2-pirrolidon-5-carbonilamido)-3-mercaptopropionico, per il trattamento di malattie connesse auna carenza di glutatione
IT1229653B (it) Procedimento per la preparazione di un derivato dell'acido n-acetil-6amminoesanoico.
LV5622A3 (lv) Panemiens aizvietotu 1,3,4,9-tetrahidropirano(3,4-b)indol-1-il-etikskabju vai to farmaceitiski saderigu salu iegusanai
NO905569L (no) Fremgangsmaate for fremstilling av fettsyrehalogenider.

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970311